The CEO of Petmed Express Inc (NASDAQ:PETS), Mederes Akdag sold 10,000 shares on December, 13. The company only reported this trading on December, 14. However, many are wondering whether or not it is time to sell out.
According to the form filed for this matter, each share was sold at $23, for a total value of $230,000. This, however, was sold by various executives in the company. The cause behind why remains unknown.
Others who sold their shares in Petmed
Examples of high-ranking employees who decided it was time to sell include the likes of Bruce S Rosenbloom, who serves as the Chief Financial Advisor for Petmed, this individual sold 1,500 shares for a premium $23 per share.
The CEO & President himself was responsible for selling 3,107 shares, which were priced at a low of $22.75 per share. Additionally, back in the past, Frank J Formica, who serves as director of Petmed sold 10,000 shares, all at a price of $21,75.
Way back, on August 12, Robert C Schweitzer, also a director for the firm sold 3,000 of his shares for $20.59 per share. The shares for this company ended up in the red, due to volatile trading, which was incurred through various executives selling their shares.
Market statistics for Petmed
On Wednesday, shares closed at a red of $23.37, which was in the red with a decrease of $0.12 or 0.51%. The intraday price for the day fluctuated to a high of $23.78. Following the close of the market, it can be seen that currently, Petmed has a market value of $493.57 million and the price to earnings ratio is 21.78.
The 52-week high of the stock is $23.78 and low is $15.73 the stock is currently close to its highs.
